Pharmaceutical Grade, Diclofenac Sodium, Manufacturer of Diclofenac Sodium, GMP

• Customization: Available
• Application: All
• Usage Mode: Injection
• Model NO.: Pharmaceutical SLL-009
• State: Liquid
• Shape: Oral Liquid
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Class: Pharmaceutical
• Transport Package: Box
• Specification: 10mg/vial, 100vial/box
• Trademark: SHENGLU
• Origin: China
• HS Code: 29225090
• Production Capacity: 100000000000000/Year

Product Description

Pharmaceutical grade ,Diclofenac sodium ,manufacturer of diclofenac sodium , GMP

Diclofenac sodium injection, the indications are
1. for the relief of rheumatoid arthritis, osteoarthritis, spondyloarthropathies, gouty arthritis, rheumatoid arthritis and other chronic arthritis of the acute attack of the joints of the symptoms of swelling and pain.
2. to relieve the acute attack of the soft tissues of the rheumatic pain, such as shoulder pain, tenosynovitis, bursitis, myalgia and so on.
3. the acute mild, moderate pain, such as: post-surgery, after traumatic injuries, Acute mild and moderate pain such as: post-surgery, post-trauma, post-strain and post-exercise injurious pain, primary dysmenorrhea, toothache, headache, etc.
4.It has an antipyretic effect on fever in adults and children.
contraindication (medicine):
1). Prohibited for those who are allergic to aspirin or other non-steroidal anti-inflammatory drugs or have a history of asthma.
2). Contraindicated for pregnant and lactating women.

Cautions :
1). This product is not a therapeutic agent for the treatment of etiology, nor can it control the course of chronic arthritis.
2). Use with caution if you have a history of peptic ulcer or ulcer bleeding.
3.) Use with caution in patients with hepatic or renal impairment or ulcers. Especially the elderly. Liver and renal function should be routinely followed up and checked during the period of use.
4.) This product contains sodium, should be used with caution in patients with restricted sodium intake.
5). Interference with diagnosis: This product may cause transient elevation of serum aminotransferase, decrease in serum uric acid content, and increase in uric acid content.
6). If gastrointestinal bleeding, hepatic and renal function damage, visual impairment, blood abnormalities and allergic reactions occur during the use of the drug, the drug should be discontinued.